These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30071045)

  • 1. Reversible covalent direct thrombin inhibitors.
    Sivaraja M; Pozzi N; Rienzo M; Lin K; Shiau TP; Clemens DM; Igoudin L; Zalicki P; Chang SS; Estiarte MA; Short KM; Williams DC; Datta A; Di Cera E; Kita DB
    PLoS One; 2018; 13(8):e0201377. PubMed ID: 30071045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis.
    Sivaraja M; Clemens DM; Sizikov S; Dash S; Xu C; Rienzo M; Yang B; Ryan M; Chattopadhyay M; Igoudin L; Chang SS; Keutzer S; Zalicki P; Estiarte MA; Shiau TP; Short KM; Williams DC; Datta A; Pozzi N; Di Cera E; Gibson CM; Fox KAA; Kita DB
    Thromb Res; 2020 Jun; 190():112-121. PubMed ID: 32339947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential profiles of thrombin inhibitors (heparin, hirudin, bivalirudin, and dabigatran) in the thrombin generation assay and thromboelastography in vitro.
    Xu Y; Wu W; Wang L; Chintala M; Plump AS; Ogletree ML; Chen Z
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):332-8. PubMed ID: 23348428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation: the present and future.
    Van Aken H; Bode C; Darius H; Diehm C; Encke A; Gulba DC; Haas S; Hacke W; Puhl W; Quante M; Riess H; Scharf R; Schellong S; Schrör T; Schulte KL; Tebbe U
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):195-204. PubMed ID: 11441979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin inhibitor design.
    Sanderson PE; Naylor-Olsen AM
    Curr Med Chem; 1998 Aug; 5(4):289-304. PubMed ID: 9668196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
    Wakui M; Fujimori Y; Nakamura S; Kondo Y; Kuroda Y; Oka S; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2019 Dec; 72(12):817-824. PubMed ID: 31366633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liporetro-D-peptides - a novel class of highly selective thrombin inhibitors.
    Poyarkov AA; Poyarkova SA; Smirnova IV; Kukhar VP
    Thromb Res; 2012 Apr; 129(4):e97-105. PubMed ID: 22079445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family of arginal thrombin inhibitors related to efegatran.
    Smith GF; Shuman RT; Craft TJ; Gifford DS; Kurz KD; Jones ND; Chirgadze N; Hermann RB; Coffman WJ; Sandusky GE; Roberts E; Jackson CV
    Semin Thromb Hemost; 1996; 22(2):173-83. PubMed ID: 8807715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
    Obst U; Banner DW; Weber L; Diederich F
    Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of in vitro effects of direct thrombin inhibitors and activated factor X inhibitors through clot waveform analysis.
    Wakui M; Fujimori Y; Katagiri H; Nakamura S; Kondo Y; Kuroda Y; Nakagawa T; Shimizu N; Murata M
    J Clin Pathol; 2019 Mar; 72(3):244-250. PubMed ID: 30518630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation.
    Incampo F; Carrieri C; Semeraro N; Colucci M
    Thromb Res; 2014 Nov; 134(5):1110-6. PubMed ID: 25193406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.
    Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):97-103. PubMed ID: 17287624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on recent patents on thrombin inhibitors (2010 - 2013).
    Mehta AY; Jin Y; Desai UR
    Expert Opin Ther Pat; 2014 Jan; 24(1):47-67. PubMed ID: 24099091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anticoagulant agents: direct thrombin inhibitors.
    Nutescu EA; Shapiro NL; Chevalier A
    Clin Geriatr Med; 2006 Feb; 22(1):33-56, viii. PubMed ID: 16377466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-Quadruplex Aptamers to Human Thrombin Versus Other Direct Thrombin Inhibitors: The Focus on Mechanism of Action and Drug Efficiency as Anticoagulants.
    Zavyalova E; Ustinov N; Golovin A; Pavlova G; Kopylov A
    Curr Med Chem; 2016; 23(21):2230-44. PubMed ID: 27183984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argatroban.
    Kathiresan S; Shiomura J; Jang IK
    J Thromb Thrombolysis; 2002 Feb; 13(1):41-7. PubMed ID: 11994559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
    Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
    J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.